Skin itching, Allergic conjunctivitis, Allergic rhinitis, Eczema, Insect bites, Dermatitis, Pollinosis, Urticaria, Neurodermitis, Allergy
Allergic diseases (incl. urticaria, serum sickness, pollinosis, or hay fever, rhinitis, conjunctivitis);
anaphylactic shock and angioedema; skin diseases (including
Prevention and treatment of allergic and pseudoallergic reactions to medications and diagnostic preparations; itching and insect bites; SARS.
.
Active ingredient
Composition
1 tablet contains chloropyramine hydrochloride 25 mg;
excipients:
lactose,
starch,
talc,
sodium amylopectin,
gelatin,
stearic acid.
How to take, the dosage
Adults are prescribed 25 mg (1 tablet) 3-4 times daily (75-100 mg/day).
For children aged 1-12 months, prescribe 1/4 tablet (6.25 mg) 2-3 times daily (crumbled to powder with baby food); 2-6 years old, 1/3 tablet (8.3 mg) 2-3 times daily; 7-14 years old, 1/2 tablet (12.5 mg) 3 times daily.
The tablets should be taken after meals.
Interaction
In concomitant use Suprastin increases the effects of anesthetics, hypnotics, tranquilizers, analgesics, MAO inhibitors, tricyclic antidepressants, atropine and sympatholytics.
When Suprastin and caffeine or phenamine are used concomitantly the CNS suppressive effect of Suprastin is reduced or eliminated.
Special Instructions
The drug should be used with caution in elderly patients, in liver dysfunction and/or heart disease. Particular caution should be exercised when prescribing the drug orally in closed-angle glaucoma, in patients with urinary retention and prostatic hypertrophy.
The drug may increase the symptoms of reflux esophagitis if taken at night.
With caution, Suprastin should be administered simultaneously with sedatives, tranquilizers, analgesics, MAO inhibitors, tricyclic antidepressants, atropine and/or sympatholytics.
Periods of alcoholic beverages should be avoided during treatment.
Influence on driving and operating machinery
In the initial, individually determined period of use of Suprastin, it is not allowed to drive vehicles and engage in other potentially dangerous activities requiring rapid psychomotor reactions.
In further treatment, the degree of restriction is determined according to individual tolerance of the drug.
Contraindications
With caution: closed-angle glaucoma; urinary retention; prostatic hyperplasia; hepatic and/or renal dysfunction; cardiovascular disease; elderly patients.
Side effects
CNS disorders: drowsiness, drowsiness, weakness, mild tremor, dizziness are possible. In children there may be some stimulating effect on the CNS, manifested by anxiety, increased irritability, insomnia.
In the digestive system: dry mouth, nausea, vomiting, diarrhea or constipation are possible.
Cardiovascular system disorders: rarely – decreased BP (more often in elderly patients), tachycardia, arrhythmia.
Allergic reactions: skin rash and itching are possible.
Others: rarely – difficulty in urination.
Overdose
Symptoms similar to those of atropine intoxication may occur.
Treatment:
There are no specific antidotes, so symptomatic treatment is carried out.
In the period of up to 12 hours after taking the drug Suprastin gastric lavage is necessary (note that gastric emptying is prevented by the anticholinergic effect of the drug). The use of activated charcoal is also indicated.
Control of blood pressure and respiratory parameters is necessary.
Pregnancy use
Pregnancy
There have been no adequately controlled clinical trials of antihistamines in pregnant women. However, cases of retrolental fibroplasia have been described in infants whose mothers took antihistamines in the last months of pregnancy. Accordingly, the use of Suprastin® during pregnancy is contraindicated.
Breast-feeding
Use of the drug Suprastin® is contraindicated during breast-feeding.
Similarities
Weight | 0.015 kg |
---|---|
Shelf life | 5 years |
Conditions of storage | At room temperature |
Manufacturer | EGIS, Hungary |
Medication form | pills |
Brand | EGIS |
Other forms…
Related products
Buy Suprastin, tablets 25 mg 20 pcs with delivery to USA, UK, Europe and over 120 other countries.